Literature DB >> 31511906

[Acute renal failure and rare severe complication of systemic steroid treatment in a 73-year-old woman].

J Bramstedt1, J U Becker2, R Wrede3, S Schmiedel4, C Riemer5, W Back6.   

Abstract

This article reports about a 73-year-old woman of Bosnian descent who presented with acute renal failure. A renal biopsy was diagnostic for a postinfect necrotizing and extracapillary proliferative glomerulonephritis. The patient reported a febrile infection fever 2 weeks previously. The diagnostics did not reveal any indications of an ongoing infection. The glomerulonephritis responded to treatment with systemic steroids. The patient was readmitted to hospital 6 weeeks later in a severely ill condition. A gastric biopsy revealed a Strongyloides stercoralis infestation. Due to the systemic steroid therapy the patient had developed a so-called hyperinfection syndrome and died despite treatment on the intensive care unit. This case illustrates the need for awareness of this rare parasitosis, particularly in patients from endemic areas. A likely causal relationship with the glomerulonephritis is discussed and an overview of the diagnostics, course of the disease and treatment of this parasitosis is given.

Entities:  

Keywords:  Hyperinfection; Immunosuppression; Ivermectin; Prednisolone; Strongyloides stercoralis

Mesh:

Substances:

Year:  2019        PMID: 31511906     DOI: 10.1007/s00108-019-00677-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  32 in total

Review 1.  Strongyloides stercoralis infection.

Authors:  Daniel Greaves; Sian Coggle; Christopher Pollard; Sani H Aliyu; Elinor M Moore
Journal:  BMJ       Date:  2013-07-30

2.  Minimal change nephrotic syndrome in association with strongyloidiasis.

Authors:  Y P Hsieh; Y K Wen; M L Chen
Journal:  Clin Nephrol       Date:  2006-12       Impact factor: 0.975

3.  High throughput multiplex PCR and probe-based detection with Luminex beads for seven intestinal parasites.

Authors:  Mami Taniuchi; Jaco J Verweij; Zannatun Noor; Shihab U Sobuz; Lisette van Lieshout; William A Petri; Rashidul Haque; Eric R Houpt
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

Review 4.  Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management.

Authors:  Sue Lim; Kevin Katz; Sigmund Krajden; Milan Fuksa; Jay S Keystone; Kevin C Kain
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

Review 5.  [Chronic recurrent subileus due to Strongyloides stercoralis infection under immunosuppressive therapy].

Authors:  R Birck; C Braun; W Back; T Gottstein; P Rohmeiss; B C Manegold; M Strauch; N Gretz
Journal:  Dtsch Med Wochenschr       Date:  1996-05-31       Impact factor: 0.628

Review 6.  Strongyloides stercoralis in the Immunocompromised Population.

Authors:  Paul B Keiser; Thomas B Nutman
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

Review 7.  Strongyloides stercoralis: Global Distribution and Risk Factors.

Authors:  Fabian Schär; Ulf Trostdorf; Federica Giardina; Virak Khieu; Sinuon Muth; Hanspeter Marti; Penelope Vounatsou; Peter Odermatt
Journal:  PLoS Negl Trop Dis       Date:  2013-07-11

8.  Strongyloides stercoralis: The Most Prevalent Parasitic Cause of Eosinophilia in Gilan Province, Northern Iran.

Authors:  K Ashrafi; A Tahbaz; B Rahmati
Journal:  Iran J Parasitol       Date:  2010-09       Impact factor: 1.012

Review 9.  A Fatal Strongyloides Stercoralis Hyperinfection Syndrome in a Patient With Chronic kidney Disease: A Case Report and Literature Review.

Authors:  Ting-Ting Qu; Qing Yang; Mei-Hong Yu; Jie Wang
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

10.  Strongyloides stercoralis, Eosinophilia, and Type 2 Diabetes Mellitus: The Predictive Value of Eosinophilia in the Diagnosis of S stercoralis Infection in an Endemic Community.

Authors:  Russell Hays; Fintan Thompson; Adrian Esterman; Robyn McDermott
Journal:  Open Forum Infect Dis       Date:  2016-02-11       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.